Skip to content

Clinical Study On The Comparative Effects Of Zimad Versus Thuja Ointment In Verruca Vulgaris (Thaalil)

Clinical Study On The Comparative Efficacy Of Zimad Versus Thuja Ointment In Verruca Vulgaris (Thaalil) - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/069534
Enrollment
48
Registered
2024-06-26
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

Interventions

Intervention1: Zimaad (Ointment)Of Shab-i-yemeni biryan, Tinkar biryan, Noshadar Kaat safaid / katthaa: Clinical study on the comparative Efficacy of ?im ?d versus Thuja ointment in Verruca vulgaris

Sponsors

National Institute Of Unani Medicine
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: •Includes all gender with age More then 10 years and above. •Diagnosed cases of common warts over hands, head, neck and face. •Subjects with Warts size of Less then 10 mm and Less then 10 in number

Exclusion criteria

Exclusion criteria: •All gender patients below 10 years. •Known cases of other than common warts, infectious dermatoses, immunocompromised •Subjects who received treatment for warts in the past 2 weeks.

Design outcomes

Primary

MeasureTime frame
Complete Removal Of lesions (warts)Timepoint: 0th,3rd,5th,7th,14th days

Secondary

MeasureTime frame
•Photography of lesion •Visual analogue scales (VAS) •Patient satisfaction scale (PSS) Timepoint: 0th,3rd,5th,7th,14th days

Countries

India

Contacts

Public ContactProf Mohd Aleemuddin Quamri

National Institute of Unani Medicine

drmaquamri@gmail.com9341072974

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026